| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/14/2007 | CN1303991C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative and process for preparing the same |
| 03/14/2007 | CN1303990C Sodium ferulate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303989C Zinc gluconate oral disintegrating tablet and its preparation process |
| 03/14/2007 | CN1303987C Esmolol Hydrochloride freeze dried powder for injection and its preparation method |
| 03/14/2007 | CN1303986C Patch |
| 03/14/2007 | CN1303985C Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 03/14/2007 | CN1303984C Method for prparing bee glue-ethyl cellulose microcapsule |
| 03/14/2007 | CN1303983C Novel method of the manufacture of suppositories |
| 03/14/2007 | CN1303982C Antifungal agent and preparation and use method |
| 03/14/2007 | CN1303981C Preparation method of Fuyankang medicine for treating gynecopathy |
| 03/14/2007 | CN1303980C Orally quick releasing tablet of compound red sage root, its medical uses and preparation process |
| 03/14/2007 | CN1303979C Snake gallbladder and tangerine peel dispersed tablets and preparation method thereof |
| 03/14/2007 | CN1303978C Silver ion health tooth paste |
| 03/14/2007 | CN1303977C Pro-micelle pharmaceutical compositions |
| 03/14/2007 | CN1303976C Maple knotweed mixture for intestine and stomach hualth and its manufacturing method |
| 03/14/2007 | CN1303975C Adhesive plaster for treating parotitis and its preparing method |
| 03/14/2007 | CN1303974C Carrier particles for use in dry powder inhalers |
| 03/14/2007 | CN1303967C Oral hygienic product with melatonin alkali as active substance to supply human and animal use |
| 03/14/2007 | CN1303953C Composition for acceleration of wound and burn healing and wound and burn healing dressing |
| 03/14/2007 | CN1303904C 橄榄钙片 Olive calcium |
| 03/14/2007 | CA2558601A1 Substance carrier using hollow nanoparticle of hepatitis b virus protein and liposome, and method of introducing substance into cell |
| 03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
| 03/13/2007 | US7189843 Using shear stress to produce seaweed products for preparing dairy products, meats, dessert gels, toothpaste, cosmetics, paints, films and delivery capsules |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189705 Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189417 Aqueous dispersion of amine-terminated silica particles having a narrowly controlled size range capable of coupling with an agent for diagnostic imaging, drug delivery or gene therapy |
| 03/13/2007 | US7189416 Method for stable and controlled delivery of (-)-hydroxycitric acid |
| 03/13/2007 | US7189415 Drugs for disintegration on polymer to make dispersion endothermic enthalpy of solution |
| 03/13/2007 | US7189414 Erodible polymer matrix of a hydrogel polymer such as polycarbophil blended with a hydrophobic polymer, and a drug; improves bioavailability of a drug which is susceptible to enzymatic degradation by enzymes in the intestinal tract |
| 03/13/2007 | US7189413 Drug delivery of proteins from polymeric blends |
| 03/13/2007 | US7189412 Co-micronized with solid surfactant; contains lactose and magnesium stearate; mixture with binder and disintegrator; bioavailability |
| 03/13/2007 | US7189411 Peptide/lipid complex formation by co-lyophilization |
| 03/13/2007 | US7189410 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 03/13/2007 | US7189392 Osteogenic protein with hyaluronic acid for drug delivery and tricalcium phosphate |
| 03/13/2007 | US7189384 Spraying cosmetics; covering skin defects; aqueous mixture of electrolyte, polydimethylsiloxane, surfactant, synthetic wax and metal oxide |
| 03/13/2007 | US7189351 D-tagatose as an anti-biofilm agent |
| 03/13/2007 | US7189279 Cross-linked polymeric nanoparticles and metal nanoparticles derived therefrom |
| 03/13/2007 | US7189198 Magnetically guidable carriers and methods for the targeted magnetic delivery of substances in the body |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2376540C Process for preparing amlodipine benzenesulphonate |
| 03/13/2007 | CA2355618C Polyol/oil suspensions for the sustained release of proteins |
| 03/13/2007 | CA2310847C Method for producing solvent-free non-crystalline biologically active substances |
| 03/13/2007 | CA2272633C Polymer film compositions for capsules |
| 03/13/2007 | CA2266581C Polymers containing polysaccharides such as alginates or modified alginates |
| 03/13/2007 | CA2228078C Composition for oral administration containing pyridazinone compounds |
| 03/13/2007 | CA2219280C Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 03/13/2007 | CA2210038C Stabilized albumin-free recombinant factor viii preparation having a low sugar content |
| 03/13/2007 | CA2184395C Effective dosage form for antiepileptic drugs |
| 03/13/2007 | CA2176461C Method for preparing low dose pharmaceutical products |
| 03/13/2007 | CA2176460C Method for dry blend compression of medicaments |
| 03/12/2007 | CA2559510A1 Compositions and methods for reducing vaginal ph |
| 03/12/2007 | CA2559407A1 Anhydrous composition containing an acid-acid buffer system |
| 03/12/2007 | CA2559288A1 Sprayable personal lubricant |
| 03/12/2007 | CA2559278A1 Sprayable personal lubricant |
| 03/08/2007 | WO2007028154A2 Encapsulated arsenic drugs |
| 03/08/2007 | WO2007028020A2 Liposome compositions |
| 03/08/2007 | WO2007027560A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 03/08/2007 | WO2007027494A2 Morphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino [4, 5-b] indole-1-acetamide |
| 03/08/2007 | WO2007027322A2 Applicator glove for application of staining compositions and self-tanning kit including same |
| 03/08/2007 | WO2007027315A2 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart |
| 03/08/2007 | WO2007027273A1 Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds |
| 03/08/2007 | WO2007026869A1 Antitumor agent |
| 03/08/2007 | WO2007026864A1 Method for preparation of pharmaceutical composition having improved disintegradability |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026755A1 Tablet for removal of tongue coating |
| 03/08/2007 | WO2007026672A1 General-purpose electrolyte composition for iontophoresis |
| 03/08/2007 | WO2007026645A1 Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation |
| 03/08/2007 | WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof |
| 03/08/2007 | WO2007026362A2 Cross-linked polysaccharide and protein matrices and methods for their preparation |
| 03/08/2007 | WO2007026180A2 Improvements in the stabilisation of biological materials |
| 03/08/2007 | WO2007026151A1 Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| 03/08/2007 | WO2007026145A1 Prolonged release formulations comprising anastrozole |
| 03/08/2007 | WO2007026138A1 Formulation |
| 03/08/2007 | WO2007026125A2 Anti-viral topical gel formulations containing a diuretic such as furosemide and/or a cardiac glycoside such as digoxin |
| 03/08/2007 | WO2007026124A2 Transdermal delivery means of a diuretic agent and/or cardiac glycoside agent |
| 03/08/2007 | WO2007025917A1 Biocidal composition containing nanoparticulate silver |
| 03/08/2007 | WO2007025768A1 Optically fluorescent nanoparticles |
| 03/08/2007 | WO2007025764A2 Pharmaceutical formulations for salts of monobasic acids comprising clopidogrel |
| 03/08/2007 | WO2007025695A1 Pharmaceutical composition comprising perindopril or its salts |
| 03/08/2007 | WO2007025441A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 03/08/2007 | WO2007003425A3 Spray-drying process for producing a dry carnitine powder or granulate |
| 03/08/2007 | WO2007002041A3 Drug-filled polymer films |
| 03/08/2007 | WO2006134018A3 Oral dosage form comprising an antimisuse system |
| 03/08/2007 | WO2006130510A3 Stable liquid desoximethasone compositions with reduced oxidized impurity |
| 03/08/2007 | WO2006128070A3 Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a gabab receptor agonist |
| 03/08/2007 | WO2006127934A3 Taste potentiator compositions and edible confectionery and chewing gum products containing same |
| 03/08/2007 | WO2006125818A3 Oral pharmaceutical formulation for the prevention and/or the treatment of cardiovascular and inflammatory diseases |
| 03/08/2007 | WO2006124366A8 Flavoring of drug-containing chewing gums |
| 03/08/2007 | WO2006121968A3 Method for treatment of uterine fibroid tumors |
| 03/08/2007 | WO2006111853A3 Stable solid dosage forms of acid labile drug |
| 03/08/2007 | WO2006105741A3 Topical pharmaceutical formulation containing nimesulide |
| 03/08/2007 | WO2006103198A3 Ophthalmic composition |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006081127A3 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid |
| 03/08/2007 | WO2006044595B1 Effervescent pressed gum tablet compositions |
| 03/08/2007 | WO2006023295A3 Pharmaceutical compositions comprising effervescent agents and fenofibrate |
| 03/08/2007 | WO2006023207A3 Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents |